Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date17 Nov 2020 |
100 Clinical Results associated with Beijing Huashen Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Beijing Huashen Pharmaceutical Co., Ltd.
100 Deals associated with Beijing Huashen Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Beijing Huashen Pharmaceutical Co., Ltd.